Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 451 entries
Sorted by: Best Match Show Resources per page
Public Health, Genomics and Biopolitics: Human Security Vis-À-Vis Securing 'Exception'

discipline specific-education (e.g., chemistry education, biology education, economics education)

[No authors listed]
GSID: AEHuYzfkGPgJ
AG Mukhopadhyay - … and Biopolitics: Human Security Vis-À-Vis …, 2009 - papers.ssrn.com

Abstract 'Biopower'has been the building block to address human beings as global mass with liberal government practices. The sovereign power continuously categorizes the …

Cite
Mukhopadhyay, A. G. (2009). Public Health, Genomics and Biopolitics: Human Security Vis-À-Vis Securing ‘Exception’. Genomics and Biopolitics: Human Security Vis-À-Vis Securing ‘Exception’(October 11, 2009).
Mukhopadhyay, Arun G. "Public Health, Genomics and Biopolitics: Human Security Vis-À-Vis Securing ‘Exception’." Genomics and Biopolitics: Human Security Vis-À-Vis Securing ‘Exception’(October 11, 2009) (2009).
Copy Download .nbib Format: MLA
Analysis of existing international policy evidence in public health genomics: mapping exercise.

Journal of public health research

Syurina EV, In den Bäumen TS, Feron FJ, Brand A.
PMID: 25170444
J Public Health Res. 2012 Feb 14;1(1):38-44. doi: 10.4081/jphr.2012.e8. eCollection 2012 Feb 17.

BACKGROUND: In the last decades we have seen a constant growth in the fields of science related to the use of genome-based health information. However, there is a gap between basic science research and the Public Health everyday practice....

Cite
Syurina EV, In den Bäumen TS, Feron FJ, et al. Analysis of existing international policy evidence in public health genomics: mapping exercise. J Public Health Res. 2012;1(1):38-44doi: 10.4081/jphr.2012.e8.
Syurina, E. V., In den Bäumen, T. S., Feron, F. J., & Brand, A. (2012). Analysis of existing international policy evidence in public health genomics: mapping exercise. Journal of public health research, 1(1), 38-44. https://doi.org/10.4081/jphr.2012.e8
Syurina, Elena V, et al. "Analysis of existing international policy evidence in public health genomics: mapping exercise." Journal of public health research vol. 1,1 (2012): 38-44. doi: https://doi.org/10.4081/jphr.2012.e8
Syurina EV, In den Bäumen TS, Feron FJ, Brand A. Analysis of existing international policy evidence in public health genomics: mapping exercise. J Public Health Res. 2012 Feb 14;1(1):38-44. doi: 10.4081/jphr.2012.e8. eCollection 2012 Feb 17. PMID: 25170444; PMCID: PMC4140310.
Copy Download .nbib Format: NLM
Commentary: thinking through public health genomics.

Medical anthropology quarterly

Rapp R.
PMID: 24281990
Med Anthropol Q. 2013 Dec;27(4):573-6. doi: 10.1111/maq.12062. Epub 2013 Nov 26.

No abstract available.

Cite
Rapp R. Commentary: thinking through public health genomics. Med Anthropol Q. 2013;27(4):573-6doi: 10.1111/maq.12062.
Rapp, R. (2013). Commentary: thinking through public health genomics. Medical anthropology quarterly, 27(4), 573-6. https://doi.org/10.1111/maq.12062
Rapp, Rayna. "Commentary: thinking through public health genomics." Medical anthropology quarterly vol. 27,4 (2013): 573-6. doi: https://doi.org/10.1111/maq.12062
Rapp R. Commentary: thinking through public health genomics. Med Anthropol Q. 2013 Dec;27(4):573-6. doi: 10.1111/maq.12062. Epub 2013 Nov 26. PMID: 24281990.
Copy Download .nbib Format: NLM
Rett Syndrome as a Rare Disease: A European Perspective.

Public health genomics

Townend GS, van Kranen HJ, van der Stel R, van den Berg M, Smeets E, van Waardenburg D, Curfs LM.
PMID: 25895605
Public Health Genomics. 2015;18(4):233-6. doi: 10.1159/000381139. Epub 2015 Apr 14.

No abstract available.

Cite
Townend GS, van Kranen HJ, van der Stel R, et al. Rett Syndrome as a Rare Disease: A European Perspective. Public Health Genomics. 2015;18(4):233-6doi: 10.1159/000381139.
Townend, G. S., van Kranen, H. J., van der Stel, R., van den Berg, M., Smeets, E., van Waardenburg, D., & Curfs, L. M. (2015). Rett Syndrome as a Rare Disease: A European Perspective. Public health genomics, 18(4), 233-6. https://doi.org/10.1159/000381139
Townend, Gillian S, et al. "Rett Syndrome as a Rare Disease: A European Perspective." Public health genomics vol. 18,4 (2015): 233-6. doi: https://doi.org/10.1159/000381139
Townend GS, van Kranen HJ, van der Stel R, van den Berg M, Smeets E, van Waardenburg D, Curfs LM. Rett Syndrome as a Rare Disease: A European Perspective. Public Health Genomics. 2015;18(4):233-6. doi: 10.1159/000381139. Epub 2015 Apr 14. PMID: 25895605.
Copy Download .nbib Format: NLM
A pan-cancer analysis of prognostic genes.

PeerJ

Anaya J, Reon B, Chen WM, Bekiranov S, Dutta A.
PMID: 27047702
PeerJ. 2016 Feb 16;3:e1499. doi: 10.7717/peerj.1499. eCollection 2015.

Numerous studies have identified prognostic genes in individual cancers, but a thorough pan-cancer analysis has not been performed. In addition, previous studies have mostly used microarray data instead of RNA-SEQ, and have not published comprehensive lists of associations with...

Cite
Anaya J, Reon B, Chen WM, et al. A pan-cancer analysis of prognostic genes. PeerJ. 2016;3:e1499doi: 10.7717/peerj.1499.
Anaya, J., Reon, B., Chen, W. M., Bekiranov, S., & Dutta, A. (2015). A pan-cancer analysis of prognostic genes. PeerJ, 3e1499. https://doi.org/10.7717/peerj.1499
Anaya, Jordan, et al. "A pan-cancer analysis of prognostic genes." PeerJ vol. 3 (2015): e1499. doi: https://doi.org/10.7717/peerj.1499
Anaya J, Reon B, Chen WM, Bekiranov S, Dutta A. A pan-cancer analysis of prognostic genes. PeerJ. 2016 Feb 16;3:e1499. doi: 10.7717/peerj.1499. eCollection 2015. PMID: 27047702; PMCID: PMC4815555.
Copy Download .nbib Format: NLM
Worldwide patterns of haplotype diversity at 9p21.3, a locus associated with type 2 diabetes and coronary heart disease.

Genome medicine

Silander K, Tang H, Myles S, Jakkula E, Timpson NJ, Cavalli-Sforza L, Peltonen L.
PMID: 19463184
Genome Med. 2009 May 12;1(5):51. doi: 10.1186/gm51.

A 100 kb region on 9p21.3 harbors two major disease susceptibility loci: one for type 2 diabetes (T2D) and one for coronary heart disease (CHD). The single nucleotide polymorphisms (SNPs) associated with these two diseases in Europeans reside on...

Cite
Silander K, Tang H, Myles S, et al. Worldwide patterns of haplotype diversity at 9p21.3, a locus associated with type 2 diabetes and coronary heart disease. Genome Med. 2009;1(5):51doi: 10.1186/gm51.
Silander, K., Tang, H., Myles, S., Jakkula, E., Timpson, N. J., Cavalli-Sforza, L., & Peltonen, L. (2009). Worldwide patterns of haplotype diversity at 9p21.3, a locus associated with type 2 diabetes and coronary heart disease. Genome medicine, 1(5), 51. https://doi.org/10.1186/gm51
Silander, Kaisa, et al. "Worldwide patterns of haplotype diversity at 9p21.3, a locus associated with type 2 diabetes and coronary heart disease." Genome medicine vol. 1,5 (2009): 51. doi: https://doi.org/10.1186/gm51
Silander K, Tang H, Myles S, Jakkula E, Timpson NJ, Cavalli-Sforza L, Peltonen L. Worldwide patterns of haplotype diversity at 9p21.3, a locus associated with type 2 diabetes and coronary heart disease. Genome Med. 2009 May 12;1(5):51. doi: 10.1186/gm51. PMID: 19463184; PMCID: PMC2689443.
Copy Download .nbib Format: NLM
Tumor gene expression profiling in women with breast cancer. Test category: prognostic.

PLoS currents

Bellcross C, Dotson WD.
PMID: 20877449
PLoS Curr. 2010 Sep 02;2. doi: 10.1371/currents.RRN1178.

Differences in the expression of specific genes within breast tumors have been associated with risk of recurrence after treatment. Most women with Stage I or II node-negative breast cancer (especially when estrogen-receptor positive and treated with tamoxifen) remain disease-free...

Cite
Bellcross C, Dotson WD. Tumor gene expression profiling in women with breast cancer. Test category: prognostic. PLoS Curr. 2010;2doi: 10.1371/currents.RRN1178.
Bellcross, C., & Dotson, W. D. (2010). Tumor gene expression profiling in women with breast cancer. Test category: prognostic. PLoS currents, 2. https://doi.org/10.1371/currents.RRN1178
Bellcross, Cecelia, and Dotson, W David. "Tumor gene expression profiling in women with breast cancer. Test category: prognostic." PLoS currents vol. 2 (2010). doi: https://doi.org/10.1371/currents.RRN1178
Bellcross C, Dotson WD. Tumor gene expression profiling in women with breast cancer. Test category: prognostic. PLoS Curr. 2010 Sep 02;2. doi: 10.1371/currents.RRN1178. PMID: 20877449; PMCID: PMC2940139.
Copy Download .nbib Format: NLM
Cascade Screening for Familial Hypercholesterolemia (FH).

PLoS currents

Ned RM, Sijbrands EJ.
PMID: 21633520
PLoS Curr. 2011 May 23;3:RRN1238. doi: 10.1371/currents.RRN1238.

Familial hypercholesterolemia (FH) is an autosomal dominant disorder characterized by abnormally high concentrations of low-density lipoprotein (LDL) cholesterol in the blood, which predisposes affected persons to premature coronary heart disease (CHD) and death. FH is one of the most...

Cite
Ned RM, Sijbrands EJ. Cascade Screening for Familial Hypercholesterolemia (FH). PLoS Curr. 2011;3:RRN1238doi: 10.1371/currents.RRN1238.
Ned, R. M., & Sijbrands, E. J. (2011). Cascade Screening for Familial Hypercholesterolemia (FH). PLoS currents, 3RRN1238. https://doi.org/10.1371/currents.RRN1238
Ned, Renée M, and Sijbrands, Eric J G. "Cascade Screening for Familial Hypercholesterolemia (FH)." PLoS currents vol. 3 (2011): RRN1238. doi: https://doi.org/10.1371/currents.RRN1238
Ned RM, Sijbrands EJ. Cascade Screening for Familial Hypercholesterolemia (FH). PLoS Curr. 2011 May 23;3:RRN1238. doi: 10.1371/currents.RRN1238. PMID: 21633520; PMCID: PMC3102597.
Copy Download .nbib Format: NLM
Current priorities for public health practice in addressing the role of human genomics in improving population health.

American journal of preventive medicine

Khoury MJ, Bowen MS, Burke W, Coates RJ, Dowling NF, Evans JP, Reyes M, St Pierre J.
PMID: 21406285
Am J Prev Med. 2011 Apr;40(4):486-93. doi: 10.1016/j.amepre.2010.12.009.

In spite of accelerating human genome discoveries in a wide variety of diseases of public health significance, the promise of personalized health care and disease prevention based on genomics has lagged behind. In a time of limited resources, public...

Cite
Khoury MJ, Bowen MS, Burke W, et al. Current priorities for public health practice in addressing the role of human genomics in improving population health. Am J Prev Med. 2011;40(4):486-93doi: 10.1016/j.amepre.2010.12.009.
Khoury, M. J., Bowen, M. S., Burke, W., Coates, R. J., Dowling, N. F., Evans, J. P., Reyes, M., & St Pierre, J. (2011). Current priorities for public health practice in addressing the role of human genomics in improving population health. American journal of preventive medicine, 40(4), 486-93. https://doi.org/10.1016/j.amepre.2010.12.009
Khoury, Muin J, et al. "Current priorities for public health practice in addressing the role of human genomics in improving population health." American journal of preventive medicine vol. 40,4 (2011): 486-93. doi: https://doi.org/10.1016/j.amepre.2010.12.009
Khoury MJ, Bowen MS, Burke W, Coates RJ, Dowling NF, Evans JP, Reyes M, St Pierre J. Current priorities for public health practice in addressing the role of human genomics in improving population health. Am J Prev Med. 2011 Apr;40(4):486-93. doi: 10.1016/j.amepre.2010.12.009. PMID: 21406285; PMCID: PMC5624316.
Copy Download .nbib Format: NLM
'No thanks'-reasons why pregnant women declined an offer of cystic fibrosis carrier screening.

Journal of community genetics

Ioannou L, Massie J, Lewis S, McClaren B, Collins V, Delatycki MB.
PMID: 23715719
J Community Genet. 2014 Apr;5(2):109-17. doi: 10.1007/s12687-013-0151-3. Epub 2013 May 29.

The objective of this study was to assess attitudes and opinions of women declining the offer of cystic fibrosis (CF) carrier screening through a population-based programme in Victoria, Australia. Between December 2009 and May 2011, women declining an offer...

Cite
Ioannou L, Massie J, Lewis S, et al. 'No thanks'-reasons why pregnant women declined an offer of cystic fibrosis carrier screening. J Community Genet. 2013;5(2):109-17doi: 10.1007/s12687-013-0151-3.
Ioannou, L., Massie, J., Lewis, S., McClaren, B., Collins, V., & Delatycki, M. B. (2014). 'No thanks'-reasons why pregnant women declined an offer of cystic fibrosis carrier screening. Journal of community genetics, 5(2), 109-17. https://doi.org/10.1007/s12687-013-0151-3
Ioannou, L, et al. "'No thanks'-reasons why pregnant women declined an offer of cystic fibrosis carrier screening." Journal of community genetics vol. 5,2 (2014): 109-17. doi: https://doi.org/10.1007/s12687-013-0151-3
Ioannou L, Massie J, Lewis S, McClaren B, Collins V, Delatycki MB. 'No thanks'-reasons why pregnant women declined an offer of cystic fibrosis carrier screening. J Community Genet. 2014 Apr;5(2):109-17. doi: 10.1007/s12687-013-0151-3. Epub 2013 May 29. PMID: 23715719; PMCID: PMC3955462.
Copy Download .nbib Format: NLM
Genetic Associations with Plasma B12, B6, and Folate Levels in an Ischemic Stroke Population from the Vitamin Intervention for Stroke Prevention (VISP) Trial.

Frontiers in public health

Keene KL, Chen WM, Chen F, Williams SR, Elkhatib SD, Hsu FC, Mychaleckyj JC, Doheny KF, Pugh EW, Ling H, Laurie CC, Gogarten SM, Madden EB, Worrall BB, Sale MM.
PMID: 25147783
Front Public Health. 2014 Aug 06;2:112. doi: 10.3389/fpubh.2014.00112. eCollection 2014.

BACKGROUND: B vitamins play an important role in homocysteine metabolism, with vitamin deficiencies resulting in increased levels of homocysteine and increased risk for stroke. We performed a genome-wide association study (GWAS) in 2,100 stroke patients from the Vitamin Intervention...

Cite
Keene KL, Chen WM, Chen F, et al. Genetic Associations with Plasma B12, B6, and Folate Levels in an Ischemic Stroke Population from the Vitamin Intervention for Stroke Prevention (VISP) Trial. Front Public Health. 2014;2:112doi: 10.3389/fpubh.2014.00112.
Keene, K. L., Chen, W. M., Chen, F., Williams, S. R., Elkhatib, S. D., Hsu, F. C., Mychaleckyj, J. C., Doheny, K. F., Pugh, E. W., Ling, H., Laurie, C. C., Gogarten, S. M., Madden, E. B., Worrall, B. B., & Sale, M. M. (2014). Genetic Associations with Plasma B12, B6, and Folate Levels in an Ischemic Stroke Population from the Vitamin Intervention for Stroke Prevention (VISP) Trial. Frontiers in public health, 2112. https://doi.org/10.3389/fpubh.2014.00112
Keene, Keith L, et al. "Genetic Associations with Plasma B12, B6, and Folate Levels in an Ischemic Stroke Population from the Vitamin Intervention for Stroke Prevention (VISP) Trial." Frontiers in public health vol. 2 (2014): 112. doi: https://doi.org/10.3389/fpubh.2014.00112
Keene KL, Chen WM, Chen F, Williams SR, Elkhatib SD, Hsu FC, Mychaleckyj JC, Doheny KF, Pugh EW, Ling H, Laurie CC, Gogarten SM, Madden EB, Worrall BB, Sale MM. Genetic Associations with Plasma B12, B6, and Folate Levels in an Ischemic Stroke Population from the Vitamin Intervention for Stroke Prevention (VISP) Trial. Front Public Health. 2014 Aug 06;2:112. doi: 10.3389/fpubh.2014.00112. eCollection 2014. PMID: 25147783; PMCID: PMC4123605.
Copy Download .nbib Format: NLM
2012 highlights in translational 'omics.

Genome medicine

Auffray C, Caulfield T, Khoury MJ, Lupski JR, Schwab M, Veenstra T.
PMID: 23369291
Genome Med. 2013 Jan 31;5(1):10. doi: 10.1186/gm414. eCollection 2013.

No abstract available.

Cite
Auffray C, Caulfield T, Khoury MJ, et al. 2012 highlights in translational 'omics. Genome Med. 2013;5(1):10doi: 10.1186/gm414.
Auffray, C., Caulfield, T., Khoury, M. J., Lupski, J. R., Schwab, M., & Veenstra, T. (2013). 2012 highlights in translational 'omics. Genome medicine, 5(1), 10. https://doi.org/10.1186/gm414
Auffray, Charles, et al. "2012 highlights in translational 'omics." Genome medicine vol. 5,1 (2013): 10. doi: https://doi.org/10.1186/gm414
Auffray C, Caulfield T, Khoury MJ, Lupski JR, Schwab M, Veenstra T. 2012 highlights in translational 'omics. Genome Med. 2013 Jan 31;5(1):10. doi: 10.1186/gm414. eCollection 2013. PMID: 23369291; PMCID: PMC3707050.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 451 entries